COURSE DESCRIPTION: 
Join us for a focused CME session on "From Vaso-Occlusion to Organ Failure: Managing Acute Complications of Sickle Cell Disease," presented by Dr. Cole Oladipo, M.D., MBA. In this session, Dr. Oladipo will review the clinical presentation and underlying pathophysiology of common acute complications of sickle cell disease, including vaso-occlusive crises, acute chest syndrome, stroke, and splenic sequestration. Participants will explore evidence-based approaches to evaluation, acute management, transfusion strategies, and escalation of care in emergency and inpatient settings. The lecture will also highlight multidisciplinary and preventive interventions aimed at reducing morbidity, mortality, and recurrent hospitalizations among individuals living with sickle cell disease.

TARGET AUDIENCE:

Internal Medicine Physicians, Cardiologists, Pulmonologists, Oncologists, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Recognize the clinical presentation and pathophysiology of common acute complications of sickle cell disease, including vaso-occlusive crises, acute chest syndrome, stroke, and splenic sequestration.
• Apply evidence-based strategies for the evaluation and management of acute sickle cell disease complications in both inpatient and emergency care settings.
• Identify indications for blood transfusion, exchange transfusion, and escalation of care in patients with severe or life-threatening sickle cell disease complications.
• Implement multidisciplinary approaches and preventive strategies to reduce morbidity, mortality, and recurrent hospitalizations among patients with sickle cell disease.

FACULTY AND DISCLOSURES:

Oladipo Cole, M.D., MBA 
Assistant Professor of Medicine 
University of Connecticut School of Medicine 
Division of Hematology/Oncology 
Associate Director Connecticut Bleeding Disorder Center 
Associate Director New England Sickle Cell Institute 
Farmington, Connecticut

Oladipo Cole, M.D., MBA, faculty for this educational activity, indicated that he is a consultant for Agios and Novo Nordisk. He has indicated that the presentation or discussion will not include off-label or unapproved product usage.  All of the relevant financial relationships listed for these individuals have been mitigated.

John F. Rubin, M.D., FACP, director for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-1296402, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Laboratory Personnel, Athletic Trainers and Respiratory Techs. Baptist Health South Florida CE Broker Provider #50-182.